Streetbeat News

Stock Prices

NCPL

Netcapital has announced the launch of the beta version of its secondary trading platform, which aims to facilitate the trading of private company shares.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 12:08 pm

COCP

Cocrystal Pharma, Inc. (NASDAQ:COCP) reported favorable safety and tolerability results from the single-ascending dose cohorts of its Phase 1 study with CDI-988, an oral pan-viral protease inhibitor targeting norovirus and coronaviruses.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 12:08 pm

LQDA

Five analysts have shared their evaluations of Liquidia (NASDAQ:LQDA) over the past three months, with all ratings being bullish. The average 12-month price target is $29.6, with a high of $32.00 and a low of $28.00. Liquidia faces challenges in revenue growth, net margin, ROE, and ROA, but maintains a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 12:07 pm

HLIT

Harmonic Inc. (NASDAQ: HLIT) received mixed analyst ratings, with 4 analysts maintaining a 'Buy' rating and setting a 12-month price target of $18.00. Despite a decline in revenue growth, the company shows strong net margins and effective debt management.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 12:07 pm

OPK

OPKO Health has announced a $100 million share buyback program, indicating confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 12:07 pm

EQT

Analysts have recently evaluated EQT (NYSE:EQT), with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased by 6.67% to $48.0. Despite positive analyst sentiment, EQT faces challenges in revenue growth, net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 12:07 pm

BIOR

Biora Therapeutics has announced the presentation of supplemental data from its Phase 1 BT-600 trial. The data confirms that the NaviCap platform effectively delivers medication topically throughout the entire colon with lower systemic concentrations.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 12:07 pm

OPK

OPKO Health has announced a $100 million share buyback program, indicating confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 12:07 pm

HUBG

Over the past three months, 8 analysts have evaluated Hub Group (NASDAQ:HUBG), with opinions ranging from bullish to bearish. The average 12-month price target is now $44.88, a 4.0% decrease from the previous $46.75. Analysts have recently lowered their ratings and price targets, reflecting changing market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 12:00 pm

BCTX

BriaCell reports extended progression-free survival to 9.1 months in ADC resistant metastatic breast cancer patients. A top responder continues Bria-IMT treatment in a Phase 2 study, showing significant reduction of a 'eye-bulging' tumor after failing 8 prior regimens.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 11:58 am